AR027924A1 - Formulacion y sus usos - Google Patents

Formulacion y sus usos

Info

Publication number: AR027924A1
Authority: AR; Argentina
Prior art keywords: formulation
Prior art date: 2000-01-14

Application number

ARP010100157A

Other languages

English (en)

Original Assignee

Allergy Therapeutics Ltd

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-14

Filing date

2001-01-12

Publication date

2003-04-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9883730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR027924(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-12 Application filed by Allergy Therapeutics Ltd, Corixa Corp filed Critical Allergy Therapeutics Ltd

2003-04-16 Publication of AR027924A1 publication Critical patent/AR027924A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

ARP010100157A 2000-01-14 2001-01-12 Formulacion y sus usos AR027924A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0000891.2A GB0000891D0 (en)	2000-01-14	2000-01-14	Formulation

Publications (1)

Publication Number	Publication Date
AR027924A1 true AR027924A1 (es)	2003-04-16

Family

ID=9883730

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP010100157A AR027924A1 (es)	2000-01-14	2001-01-12	Formulacion y sus usos

Country Status (15)

Country	Link
US (1)	US8470331B2 (es)
EP (3)	EP1255563B2 (es)
JP (1)	JP4648603B2 (es)
AR (1)	AR027924A1 (es)
AU (1)	AU2001228625A1 (es)
CA (1)	CA2397359C (es)
CZ (1)	CZ304941B6 (es)
DE (1)	DE60139305D1 (es)
DK (1)	DK2100616T3 (es)
ES (2)	ES2328336T5 (es)
GB (2)	GB0000891D0 (es)
HU (1)	HU230545B1 (es)
PL (1)	PL356963A1 (es)
SK (1)	SK288411B6 (es)
WO (1)	WO2001051082A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060025726A1 (en) *	1996-06-04	2006-02-02	Vance Products Incorporated, D/B/A Cook Urological Incorporated	Implantable medical device with pharmacologically active layer
US20060030826A1 (en) *	1996-06-04	2006-02-09	Vance Products Incorporated,d/b/a Cook Urological Incorporated	Implantable medical device with anti-neoplastic drug
US20060052757A1 (en) *	1996-06-04	2006-03-09	Vance Products Incorporated, D/B/A Cook Urological Incorporated	Implantable medical device with analgesic or anesthetic
GB9706957D0 (en) *	1997-04-05	1997-05-21	Smithkline Beecham Plc	Formulation
GB9820525D0 (en) *	1998-09-21	1998-11-11	Allergy Therapeutics Ltd	Formulation
AU2003280324A1 (en)	2002-11-26	2004-06-18	Alk-Abello A/S	Pharmaceutical allergen product
US8012505B2 (en)	2003-02-28	2011-09-06	Alk-Abello A/S	Dosage form having a saccharide matrix
WO2005115449A1 (en) *	2004-05-28	2005-12-08	Alk-Abelló A/S	Method of treating allergy and infection by eliciting an iga antibody response
ITMI20061117A1 (it) *	2006-06-09	2007-12-10	Michele Bonanomi	Una composizione farmaceutica per la somministrazione sublinguale di vaccini metodo per la sua preparazione e sui usi
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
EP2486938B1 (en)	2006-09-26	2018-05-09	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
WO2010127144A1 (en)	2009-04-29	2010-11-04	Muniyappa Pravin K	Device and method for the diagnosis of gastrointestinal allergy
MX360448B (es)	2009-06-05	2018-11-01	Infectious Disease Res Inst	Adyuvantes sinteticos de glucopiranosil-lipido.
GB201009273D0 (en) *	2010-06-03	2010-07-21	Glaxosmithkline Biolog Sa	Novel vaccine
EA027236B1 (ru)	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
JP5650780B2 (ja)	2012-04-04	2015-01-07	日東電工株式会社	ワクチン組成物
ES2673556T3 (es)	2012-05-16	2018-06-22	Immune Design Corp.	Vacunas para el VHS-2
KR102039520B1 (ko)	2013-04-18	2019-11-01	이뮨 디자인 코포레이션	암 치료에 이용하기 위한 gla 단일요법
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
TW201709926A (zh) *	2015-04-23	2017-03-16	賽諾菲公司	用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
WO2017173398A1 (en)	2016-04-01	2017-10-05	Duke University	Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
BR112022018160A2 (pt) *	2020-03-24	2022-10-25	Byung Chul Ahn	Método de produção de composição de soro para prevenir ou tratar doenças infecciosas relacionadas à mucosa em mamíferos jovens, composição de soro produzida por ele, e uso da mesma
KR102151962B1 (ko)	2020-03-24	2020-09-04	안병철	어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1128637A (en)	1966-09-13	1968-09-25	Beecham Group Ltd	Influenza vaccine
US3541201A (en)	1968-12-18	1970-11-17	Ethan Alan Brown	Novel sodium chloride encapsulated injectionable substances
GB1377074A (en) *	1971-07-13	1974-12-11	Beecham Group Ltd	Process for preparing injectable compositions
US4070455A (en) *	1974-02-16	1978-01-24	Beecham Group Limited	Process for preparing injectable desensitizing compositions and products thereof in microparticle form
GB1492973A (en)	1974-02-16	1977-11-23	Beecham Group Ltd	Process for preparing injectable compositions
EP0182442B2 (en)	1978-12-22	1996-04-03	Biogen, Inc.	Recombinant DNA molecules and their method of production
US4258029A (en) *	1979-04-23	1981-03-24	Connaught Laboratories Limited	Synthetic adjuvants for stimulation of antigenic responses
US4436727A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
US4987237A (en)	1983-08-26	1991-01-22	Ribi Immunochem Research, Inc.	Derivatives of monophosphoryl lipid A
DE3521994A1 (de) *	1985-06-20	1987-01-02	Bayer Ag	N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US5244663A (en) *	1987-01-28	1993-09-14	Medibrevex	Therapeutic method against allergy
US4975420A (en) *	1987-09-30	1990-12-04	University Of Saskatchewan	Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
FR2621916B1 (fr) *	1987-10-19	1990-03-09	Bioeurope	Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
GB9106048D0 (en)	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccines
RU94040856A (ru) *	1992-03-03	1996-08-20	Дайити Фармасьютикал Ко.	Вакцина для перорального введения
KR100278157B1 (ko) *	1992-06-25	2001-01-15	장 스테판느	보조약을 함유하는 백신 조성물
JPH08508247A (ja) *	1993-03-11	1996-09-03	セクレテック，インク．	粘膜表面への免疫原の輸送における重合的粘膜付着体
CZ289476B6 (cs) *	1993-03-23	2002-01-16	Smithkline Beecham Biologicals (S.A.)	Očkovací přípravek a způsob jeho výroby
EP0705109B2 (en) *	1993-05-25	2004-01-02	American Cyanamid Company	Adjuvants for vaccines against respiratory syncytial virus
AU7482694A (en) *	1993-08-27	1995-03-21	Enteric Research Laboratories, Inc.	(campylobacter jejuni) antigens, and methods for their production and use
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
US5514665A (en)	1993-12-30	1996-05-07	University Of British Columbia	Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5997873A (en) *	1994-01-13	1999-12-07	Mount Sinai School Of Medicine Of The City University Of New York	Method of preparation of heat shock protein 70-peptide complexes
US5646115A (en) *	1994-10-07	1997-07-08	Heska Corporation	Ectoparasite saliva proteins and apparatus to collect such proteins
WO1996025664A1 (en)	1995-02-17	1996-08-22	Immunotherapy, Inc.	Immunotherapy screening, prognosis, and treatment methods and compositions
KR100201352B1 (ko) *	1995-03-16	1999-06-15	성재갑	단일주사 백신 제형
GB9508785D0 (en)	1995-04-29	1995-06-21	Smithkline Beecham Plc	Novel compositions
US5762943A (en) *	1996-05-14	1998-06-09	Ribi Immunochem Research, Inc.	Methods of treating type I hypersensitivity using monophosphoryl lipid A
US5973128A (en) *	1996-11-22	1999-10-26	The Hospital For Sick Children Research And Development Lp	Glycolipid mimics and methods of use thereof
DE69835424T2 (de) *	1997-03-10	2007-02-08	Immtech Biologics, LLC, Bucyrus	Boviner atmungs- und darmcoronavirus als impfstoff
US6491919B2 (en) *	1997-04-01	2002-12-10	Corixa Corporation	Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
BR9811262A (pt) *	1997-04-01	2000-10-17	Ribi Immunochem Research Inc	Composições auxiliares imunológicas aquosas de lipìdio de monofosforila a.
GB9706957D0 (en)	1997-04-05	1997-05-21	Smithkline Beecham Plc	Formulation
WO1998058956A2 (en)	1997-06-23	1998-12-30	Ludwig Institute For Cancer Research	Methods for inducing an immune response involving prime-boost protocols
GB9717953D0 (en)	1997-08-22	1997-10-29	Smithkline Beecham Biolog	Vaccine
GB9720585D0 (en)	1997-09-26	1997-11-26	Smithkline Beecham Biolog	Vaccine
AU750173B2 (en) *	1997-11-10	2002-07-11	Statens Serum Institut	Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
WO1999064074A1 (en) *	1998-06-11	1999-12-16	The Trustees Of The University Of Pennsylvania	Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage
CA2330209A1 (en)	1998-06-12	1999-12-23	Smithkline Beecham Biologicals S.A.	Recombinant production of toxoplasma sag1 antigen
WO2000000218A1 (fr)	1998-06-26	2000-01-06	Aventis Pasteur	Immunisation a ciblage mucosal
GB9820525D0 (en) *	1998-09-21	1998-11-11	Allergy Therapeutics Ltd	Formulation
US6734172B2 (en) *	1998-11-18	2004-05-11	Pacific Northwest Research Institute	Surface receptor antigen vaccines
EP1031347B1 (en) *	1999-01-27	2002-04-17	Idea Ag	Transnasal transport/immunisation with highly adaptable carriers
CA2366688A1 (en)	1999-02-26	2000-08-31	Chiron Corporation	Use of bioadhesives and adjuvants for the mucosal delivery of antigens
GB9909077D0 (en) *	1999-04-20	1999-06-16	Smithkline Beecham Biolog	Novel compositions
SK14832001A3 (sk) *	1999-04-23	2003-02-04	Pharmexa A/S	Analóg interleukínu 5, fragment nukleovej kyseliny, vektor, bunka, prípravky a použitie
UA81216C2 (en) *	1999-06-01	2007-12-25		Prevention and treatment of amyloid disease
WO2000076476A1 (en)	1999-06-11	2000-12-21	Endorex Corporation	Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination
GB9924529D0 (en) *	1999-10-15	1999-12-15	Smithkline Beecham Biolog	Novel compounds
WO2001095914A1 (en) *	2000-06-14	2001-12-20	William Leslie Porter	Lipids for modulating immune response
GB0020089D0 (en) *	2000-08-15	2000-10-04	Smithkline Beecham Biolog	Vaccine Composition

2000
- 2000-01-14 GB GBGB0000891.2A patent/GB0000891D0/en active Pending
2001
- 2001-01-12 AR ARP010100157A patent/AR027924A1/es unknown
- 2001-01-15 EP EP01942305.2A patent/EP1255563B2/en not_active Expired - Lifetime
- 2001-01-15 AU AU2001228625A patent/AU2001228625A1/en not_active Abandoned
- 2001-01-15 DE DE60139305T patent/DE60139305D1/de not_active Expired - Lifetime
- 2001-01-15 CZ CZ2002-2417A patent/CZ304941B6/cs not_active IP Right Cessation
- 2001-01-15 SK SK1041-2002A patent/SK288411B6/sk not_active IP Right Cessation
- 2001-01-15 EP EP09159908.4A patent/EP2100616B1/en not_active Expired - Lifetime
- 2001-01-15 DK DK09159908.4T patent/DK2100616T3/en active
- 2001-01-15 EP EP10011044A patent/EP2322212A1/en not_active Withdrawn
- 2001-01-15 HU HU0203972A patent/HU230545B1/hu unknown
- 2001-01-15 PL PL01356963A patent/PL356963A1/xx unknown
- 2001-01-15 CA CA2397359A patent/CA2397359C/en not_active Expired - Lifetime
- 2001-01-15 WO PCT/GB2001/000142 patent/WO2001051082A1/en not_active Ceased
- 2001-01-15 US US10/181,684 patent/US8470331B2/en not_active Expired - Fee Related
- 2001-01-15 JP JP2001551505A patent/JP4648603B2/ja not_active Expired - Fee Related
- 2001-01-15 ES ES01942305.2T patent/ES2328336T5/es not_active Expired - Lifetime
- 2001-01-15 ES ES09159908.4T patent/ES2561360T3/es not_active Expired - Lifetime
- 2001-01-15 GB GB0101035A patent/GB2360210B/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HUP0203972A2 (hu)	2003-03-28
HUP0203972A3 (en)	2011-02-28
JP4648603B2 (ja)	2011-03-09
EP2322212A1 (en)	2011-05-18
US20030165512A1 (en)	2003-09-04
JP2003519669A (ja)	2003-06-24
EP2100616A2 (en)	2009-09-16
ES2328336T3 (es)	2009-11-12
GB0000891D0 (en)	2000-03-08
GB0101035D0 (en)	2001-02-28
US8470331B2 (en)	2013-06-25
EP2100616B1 (en)	2015-11-25
CA2397359C (en)	2012-06-05
SK10412002A3 (sk)	2003-05-02
ES2561360T3 (es)	2016-02-25
GB2360210A (en)	2001-09-19
EP1255563B2 (en)	2016-03-02
EP1255563A1 (en)	2002-11-13
ES2328336T5 (es)	2016-06-21
SK288411B6 (sk)	2016-10-03
AU2001228625A1 (en)	2001-07-24
WO2001051082A1 (en)	2001-07-19
EP1255563B1 (en)	2009-07-22
CZ20022417A3 (cs)	2003-03-12
DK2100616T3 (en)	2016-02-08
PL356963A1 (en)	2004-07-12
GB2360210B (en)	2004-12-15
EP2100616A3 (en)	2009-09-23
HU230545B1 (hu)	2016-11-28
CZ304941B6 (cs)	2015-02-04
DE60139305D1 (de)	2009-09-03
CA2397359A1 (en)	2001-07-19

Publication	Publication Date	Title
AR027924A1 (es)	2003-04-16	Formulacion y sus usos
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
NO20024099D0 (no)	2002-08-28	Lavdose entecavir-formulering og anvendelse
AR027938A1 (es)	2003-04-16	Compuestos uracilo y utilizacion de los mismos
DE60111534D1 (de)	2005-07-21	Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
IS6709A (is)	2003-02-06	Fljótandi samsetningar metformíns
NO20025357D0 (no)	2002-11-08	Antranylamider og deres anvendelse som legemidler
ATE263487T1 (de)	2004-04-15	Flüssige formulierungen
AR028610A1 (es)	2003-05-14	Composiciones antitranspirantes y/o desodorantes
BRPI0208558A2 (pt)	2017-05-23	preparado de combinação de estrogênio-gestagênio e uso
NO20030917D0 (no)	2003-02-27	Anvendelse
DE60125415D1 (de)	2007-02-01	Formeinsatz
NO20025158L (no)	2002-12-06	Lipidpreparat og anvendelse derav
NO20025510L (no)	2003-01-14	Dibenzoazulen-derivater samt anvendelse derav
DE50107683D1 (de)	2006-02-23	Knautschelement
DE60102459D1 (de)	2004-04-29	Lockenwickler
DE50100556D1 (de)	2003-10-02	Knautschelement
DE60212612D1 (de)	2006-08-03	Farbige peroxyd- und polyester-formulierungen
ATE268116T1 (de)	2004-06-15	Mesotrion-formulierungen
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
DE50109033D1 (de)	2006-04-27	Verdickerformulierung mit verbesserter biologischer Abbaubarkeit
FR2804602B1 (fr)	2004-11-19	Preparations cosmetiques
ES1049942Y (es)	2002-06-01	Pareja de zocalo y portalamparas.

Legal Events

Date	Code	Title	Description
2013-06-24	FB	Suspension of granting procedure